Insufficient scRNA-seq data for expression of FNDC4 at single-cell level.
Insufficient scRNA-seq data for expression of FNDC4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3232.82 | 2630 / 2642 | 100% | 103.60 | 705 / 705 |
| liver | 100% | 6229.56 | 226 / 226 | 92% | 67.25 | 373 / 406 |
| adrenal gland | 100% | 10665.02 | 258 / 258 | 83% | 43.98 | 190 / 230 |
| prostate | 93% | 1000.16 | 229 / 245 | 84% | 19.81 | 424 / 502 |
| breast | 97% | 2249.85 | 446 / 459 | 58% | 10.63 | 643 / 1118 |
| ovary | 99% | 3304.79 | 179 / 180 | 54% | 8.83 | 233 / 430 |
| thymus | 65% | 474.34 | 422 / 653 | 75% | 42.22 | 456 / 605 |
| pancreas | 43% | 502.14 | 141 / 328 | 93% | 34.80 | 166 / 178 |
| esophagus | 73% | 866.88 | 1052 / 1445 | 36% | 5.73 | 66 / 183 |
| skin | 54% | 415.12 | 977 / 1809 | 50% | 12.31 | 237 / 472 |
| bladder | 57% | 385.29 | 12 / 21 | 46% | 11.47 | 234 / 504 |
| lung | 39% | 249.37 | 223 / 578 | 64% | 16.67 | 736 / 1155 |
| adipose | 100% | 2693.51 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 49% | 469.30 | 44 / 89 | 40% | 14.24 | 363 / 901 |
| uterus | 47% | 313.18 | 80 / 170 | 41% | 12.68 | 186 / 459 |
| blood vessel | 81% | 860.03 | 1081 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 42% | 299.95 | 151 / 359 | 27% | 3.85 | 77 / 286 |
| intestine | 45% | 290.34 | 430 / 966 | 22% | 4.53 | 117 / 527 |
| spleen | 53% | 365.51 | 127 / 241 | 0% | 0 | 0 / 0 |
| heart | 39% | 355.95 | 333 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 2.34 | 10 / 45 |
| muscle | 19% | 165.00 | 155 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 1.69 | 6 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.38 | 1 / 29 |
| peripheral blood | 1% | 12.13 | 6 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050728 | Biological process | negative regulation of inflammatory response |
| GO_0071559 | Biological process | response to transforming growth factor beta |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| Gene name | FNDC4 |
| Protein name | Fibronectin type III domain-containing protein 4 (Fibronectin type III repeat-containing protein 1) |
| Synonyms | FRCP1 UNQ6389/PRO21134 |
| Description | FUNCTION: Acts as an anti-inflammatory factor in the intestine and colon. Binds to and acts on macrophages to down-regulate pro-inflammatory gene expression. Affects key macrophage functions, including phagocytosis, by down-regulating many key pathways for macrophage activation, partly via by STAT3 activation and signaling. May be required to dampen the immunological response in colitis. . |
| Accessions | ENST00000264703.4 Q9H6D8 |